Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting

Patients experiencing vasoplegia, a type of distributive shock, have limited options when conventional vasopressors are not appropriate or sufficient. This is especially true for patients with cardiac dysfunction, whether after heart transplant or ventricular assist device (VAD) implantation. Angiot...

Full description

Saved in:
Bibliographic Details
Main Authors: William Sovic, Christo Mathew, Britton Blough, Kara-Ann Monday, Teena Sam, Hira Zafar, Cesar Guerrero-Miranda, Melody Sherwood, Christopher Hebert, Shelley Hall, Amit Alam
Format: Article
Language:English
Published: Houston Methodist DeBakey Heart & Vascular Center 2021-11-01
Series:Methodist DeBakey Cardiovascular Journal
Subjects:
Online Access:https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/576
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128309986263040
author William Sovic
Christo Mathew
Britton Blough
Kara-Ann Monday
Teena Sam
Hira Zafar
Cesar Guerrero-Miranda
Melody Sherwood
Christopher Hebert
Shelley Hall
Amit Alam
author_facet William Sovic
Christo Mathew
Britton Blough
Kara-Ann Monday
Teena Sam
Hira Zafar
Cesar Guerrero-Miranda
Melody Sherwood
Christopher Hebert
Shelley Hall
Amit Alam
author_sort William Sovic
collection DOAJ
description Patients experiencing vasoplegia, a type of distributive shock, have limited options when conventional vasopressors are not appropriate or sufficient. This is especially true for patients with cardiac dysfunction, whether after heart transplant or ventricular assist device (VAD) implantation. Angiotensin II has been used in various clinical settings for distributive shock; however, its role in patients after orthotopic heart transplant or VAD implantation is not well studied. We present two cases where angiotensin II played a vital role in correcting vasoplegia for critical cardiac patients.
format Article
id doaj-art-b83d233f14c34a048346f676d4e4406d
institution OA Journals
issn 1947-6108
language English
publishDate 2021-11-01
publisher Houston Methodist DeBakey Heart & Vascular Center
record_format Article
series Methodist DeBakey Cardiovascular Journal
spelling doaj-art-b83d233f14c34a048346f676d4e4406d2025-08-20T02:33:23ZengHouston Methodist DeBakey Heart & Vascular CenterMethodist DeBakey Cardiovascular Journal1947-61082021-11-01173283110.14797/mdcvj.576100Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac SettingWilliam Sovic0https://orcid.org/0000-0001-6989-3327Christo Mathew1https://orcid.org/0000-0002-3675-0909Britton Blough2https://orcid.org/0000-0003-3957-3896Kara-Ann Monday3https://orcid.org/0000-0001-7772-8145Teena Sam4https://orcid.org/0000-0002-9780-7227Hira Zafar5https://orcid.org/0000-0002-1503-1710Cesar Guerrero-Miranda6https://orcid.org/0000-0003-4665-5160Melody Sherwood7Christopher Hebert8https://orcid.org/0000-0002-3992-4046Shelley Hall9https://orcid.org/0000-0002-5989-2934Amit Alam10https://orcid.org/0000-0002-3040-3957Baylor University Medical Center, Dallas, TexasTexas A&M University College of Medicine, Bryan, TexasBaylor University Medical Center, Dallas, TexasBaylor University Medical Center, Dallas, TexasBaylor University Medical Center, Dallas, TexasBaylor University Medical Center, Dallas, TexasBaylor University Medical Center, Dallas, Texas; Texas A&M University College of Medicine, Bryan, TexasBaylor University Medical Center, Dallas, TexasBaylor University Medical Center, Dallas, TexasBaylor University Medical Center, Dallas, Texas; Texas A&M University College of Medicine, Bryan, TexasBaylor University Medical Center, Dallas, Texas; Texas A&M University College of Medicine, Bryan, TexasPatients experiencing vasoplegia, a type of distributive shock, have limited options when conventional vasopressors are not appropriate or sufficient. This is especially true for patients with cardiac dysfunction, whether after heart transplant or ventricular assist device (VAD) implantation. Angiotensin II has been used in various clinical settings for distributive shock; however, its role in patients after orthotopic heart transplant or VAD implantation is not well studied. We present two cases where angiotensin II played a vital role in correcting vasoplegia for critical cardiac patients.https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/576angiotensin iishockheart failurevasoplegia
spellingShingle William Sovic
Christo Mathew
Britton Blough
Kara-Ann Monday
Teena Sam
Hira Zafar
Cesar Guerrero-Miranda
Melody Sherwood
Christopher Hebert
Shelley Hall
Amit Alam
Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
Methodist DeBakey Cardiovascular Journal
angiotensin ii
shock
heart failure
vasoplegia
title Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
title_full Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
title_fullStr Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
title_full_unstemmed Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
title_short Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
title_sort angiotensin ii a multimodal approach to vasoplegia in a cardiac setting
topic angiotensin ii
shock
heart failure
vasoplegia
url https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/576
work_keys_str_mv AT williamsovic angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT christomathew angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT brittonblough angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT karaannmonday angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT teenasam angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT hirazafar angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT cesarguerreromiranda angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT melodysherwood angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT christopherhebert angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT shelleyhall angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting
AT amitalam angiotensiniiamultimodalapproachtovasoplegiainacardiacsetting